GREY:TSTIF - Post by User
Comment by
Drrwongon Feb 02, 2019 2:12pm
143 Views
Post# 29310317
RE:What about sales?
RE:What about sales?@Vice: what don't you bring this up with IR?
In my investing experience, almost no publicly traded companies give monthly updates on their sales or install numbers? Just look at our closest peers: JNJ, Steris, Getinge, Cantel, etc--do any one of them give anything more than a quarterly update?
Yes, we are at an early stage of commercialization, so we might not be directly comparable to these peers. But if I look at early commercial stage biotech or drug companies with only one recently launched product: they don't give monthly prescription updates either. To be fair, these early biotech companies will start giving guidance after one or two quarters post launch. So it would be a fair call for RR to give guidance at or before our AGM this year.
Keep in mind that our management has been giving us two updates every quarter since we took over from Getinge: one PR immediately after a quarter, and another PR just before the quarterly conference call, which is usually slotted around mid calender quarter (e.g.: early Nov call for Q3 results). This is already pretty good, imo.
PS: keep in mind the Q4 conference calls won't be held typically till mid March due to longer year-end audits and filings, etc., so we might not get a nicely-spaced mid-quarter update in Q1.